F. Bemelman

Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients

B. V. van Munster, A. V. van Zuilen, M. Betjes, 2021, BMC Nephrology.

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation

J. D. de Fijter, J. Swen, T. van der Straaten, 2014, CPT: pharmacometrics & systems pharmacology.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

M. Bots, J. D. de Fijter, F. V. van Ittersum, 2014, Transplant immunology.

Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation.

J. Wetzels, S. Berger, A. D. de Vries, 2023, Kidney international reports.

Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study

Reshwan K. Malahe, E. Remmerswaal, D. van Baarle, 2022, BMC Nephrology.

University of Groningen Effect of CYP 3 A 4 * 22 , CYP 3 A 5 * 3 , and CYP 3 A Combined Genotypes on Cyclosporine , Everolimus , and Tacrolimus Pharmacokinetics in Renal Transplantation

J. Swen, J. Hartigh, T. Straaten, 2014 .

A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.

K. Lopau, W. van Biesen, A. Kribben, 2023, Kidney international.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

M. Christiaans, D. Roelen, F. Claas, 2014, Transplant immunology.